Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
37 state Medicaid programs continue to restrict access to lifesaving medication—despite medical guidelines telling them not to.
Six presidential candidates answered 15 questions posed by a coalition of more than 50 AIDS groups.
The results of a poll in seven states “are alarming and should hasten our…efforts on viral suppression.” There’s also good news!
Meet Christa Weather of Open Aid Alliance in Montana.
A new analysis finds that Obamacare has driven down the proportion of individuals without insurance.
“It’s hard to be proud when your health is on the line and when stigma is beating you up,” said AIDS United’s Jesse Milan.
The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.
The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.
Medicaid covers nearly 40% of people living with HIV currently in care.
The Truvada manufacturer’s agreement with the Trump Administration is “a tremendous step toward ending the epidemic.”
Insurance companies can no longer implement harmful co-pay accumulator policies.
Pharma sets the prices for HIV and hep C drugs very high. What happens to those prices along the supply chain?
Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.
We take a look at the first-ever release of comprehensive region-level PrEP use data in New York.
The Department of Justice seeks to throw out the Affordable Care Act entirely.
In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.